OLFM4-RET fusion is an oncogenic driver in small intestine adenocarcinoma

MLA

Wenli Liu, et al. “OLFM4-RET Fusion Is an Oncogenic Driver in Small Intestine Adenocarcinoma.” Oncogene, vol. 41, no. 1, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....361a3c9e5e7c5986ae38c4b3a0443d8c&authtype=sso&custid=ns315887.

APA

Wenli Liu, Griffin P. Rodgers, Hongzhen Li, Istvan Botos, & Wulin Aerbajinai. (2021). OLFM4-RET fusion is an oncogenic driver in small intestine adenocarcinoma. Oncogene, 41(1).

Chicago

Wenli Liu, Griffin P. Rodgers, Hongzhen Li, Istvan Botos, and Wulin Aerbajinai. 2021. “OLFM4-RET Fusion Is an Oncogenic Driver in Small Intestine Adenocarcinoma.” Oncogene 41 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....361a3c9e5e7c5986ae38c4b3a0443d8c&authtype=sso&custid=ns315887.